Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCASI Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q2 2024 | 1 | -$0.63 | -$0.63 | -$0.63 |
| Q3 2024 | 1 | -$0.62 | -$0.62 | -$0.62 |
| Q4 2024 | 1 | -$0.60 | -$0.60 | -$0.60 |
| Q1 2025 | 1 | -$0.61 | -$0.61 | -$0.61 |
| Q2 2025 | 1 | -$0.54 | -$0.54 | -$0.54 |
| Q3 2025 | 1 | -$0.51 | -$0.51 | -$0.51 |
| Q4 2025 | 1 | -$0.47 | -$0.47 | -$0.47 |
CASI Pharmaceuticals, Inc. Earnings Date And Information
CASI Pharmaceuticals, Inc. last posted its earnings results on Friday, November 15th, 2024. The company reported $-0.55 earnings per share for the quarter, topping analysts' consensus estimates of $-0.62 by $0.07. The company had revenue of 7.79 M for the quarter and had revenue of 33.88 M for the year. CASI Pharmaceuticals, Inc. has generated $-2 earnings per share over the last year ($-2.02 diluted earnings per share) and currently has a price-to-earnings ratio of -1.34. CASI Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based on prior year's report dates.
CASI Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/30/2024 | Q3 2024 | -$0.55 | $4.56 M | $7.79 M | ||
| 06/28/2024 | Q2 2024 | -$0.52 | $4.43 M | $3.98 M | ||
| 03/29/2024 | Q1 2024 | -$0.71 | $3.41 M | |||
| 03/28/2024 | Q4 2023 | -$0.24 | -$0.41 | -0.17 | $6.09 M | |
| 09/29/2023 | Q3 2023 | -$0.35 | $10.43 M | $8.84 M | ||
| 06/29/2023 | Q2 2023 | -$0.77 | $10.09 M | $9.82 M | ||
| 03/30/2023 | Q1 2023 | -$0.45 | $8.35 M | |||
| 04/26/2023 | Q4 2022 | -$0.64 | -$1.37 | -0.73 | $15.26 M | |
| 11/14/2022 | Q3 2022 | -$0.51 | -$0.28 | 0.23 | $9.91 M | $10.21 M |
| 08/12/2022 | Q2 2022 | -$0.65 | -$0.56 | 0.09 | $7.87 M | $8.57 M |
| 05/12/2022 | Q1 2022 | -$1.00 | -$0.70 | 0.3 | $9.06 M | |
| 03/28/2022 | Q4 2021 | -$0.60 | -$0.04 | 0.56 | $9.16 M | |
| 11/12/2021 | Q3 2021 | -$0.60 | -$0.73 | -0.13 | $7.53 M | $8.11 M |
| 08/12/2021 | Q2 2021 | -$0.50 | $6.02 M | $7.16 M | ||
| 05/13/2021 | Q1 2021 | -$0.50 | -$1.11 | -0.61 | $5.74 M | |
| 03/30/2021 | Q4 2020 | -$0.70 | -$0.12 | 0.58 | $4.82 M | |
| 11/09/2020 | Q3 2020 | -$0.60 | -$1.44 | -0.84 | $3.44 M | $4.24 M |
| 08/10/2020 | Q2 2020 | -$0.80 | -$0.86 | -0.06 | $3.75 M | $2.67 M |
| 05/11/2020 | Q1 2020 | -$1.10 | -$0.85 | 0.25 | $3.41 M | |
| 03/16/2020 | Q4 2019 | -$1.10 | -$0.13 | 0.97 | $1.34 M |
CASI Pharmaceuticals, Inc. Earnings: FAQ's
When is CASI Pharmaceuticals, Inc.'s earnings date?
CASI Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based off last year's report dates.
Did CASI Pharmaceuticals, Inc. beat their earnings estimates last
quarter?
In the previous quarter, CASI Pharmaceuticals, Inc. (:CASI) reported $-0.55 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.62 by $0.07.
How can I listen to CASI Pharmaceuticals, Inc.'s earnings conference
call?
The conference call for CASI Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
How can I read CASI Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for CASI Pharmaceuticals, Inc.'s latest earnings report can be read online.
How much revenue does CASI Pharmaceuticals, Inc. generate each year?
CASI Pharmaceuticals, Inc. (:CASI) has a recorded annual revenue of $33.88 M.
How much profit does CASI Pharmaceuticals, Inc. generate each year?
CASI Pharmaceuticals, Inc. (:CASI) has a recorded net income of $33.88 M. CASI Pharmaceuticals, Inc. has generated $-2.02 earnings per share over the last four quarters.
What is CASI Pharmaceuticals, Inc.'s price-to-earnings ratio?
CASI Pharmaceuticals, Inc. (:CASI) has a price-to-earnings ratio of -1.34 and price/earnings-to-growth ratio is 0.13.